$165.11
+10.27 (+6.63%)
At Close: Jun 03, 2026
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs June 23)
ACADIA Pharmaceuticals Inc...
Alpine Immune Sciences, Inc. : The underlying trend is to the upside | MarketScreener
01:28pm, Tuesday, 23'rd Jun 2020Alpine Immune Sciences, Inc. : La tendance est haussière | Zone bourse
01:28pm, Tuesday, 23'rd Jun 2020Nokia chosen as key fibre-network supplier for National Broadband Plan
09:40am, Tuesday, 23'rd Jun 2020
National Broadband Ireland has chosen Nokia to deploy its fibre network technology as part of the National Broadband Plan.
Nokia : un contrat avec Toyota, un autre avec l'Irlande | Zone bourse
09:24am, Tuesday, 23'rd Jun 2020Nokia : un contrat avec Toyota, un autre avec l'Irlande
09:16am, Tuesday, 23'rd Jun 2020
(CercleFinance.com) - Nokia a annoncé mardi avoir été sélectionné par Toyota afin de déployer un réseau sans fil industriel au sein d'un centre de conception et de fabrication basé à Fukuoka
The Daily Biotech Pulse: Sanofi Expedites COVID-19 Vaccine Timeline, Apyx Cleared For Market Expansion, Miragen's Positive Readout
12:00am, Tuesday, 23'rd Jun 2020
The following is a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs June 22)
ADC Therapeutics SA (...
Leigh Creek progresses with flagship project - DirectorsTalk
09:16am, Monday, 22'nd Jun 2020
Leigh Creek Energy (LCK) has completed 12 months of environmental monitoring at its flagship project in South Australia following the finalisation of its pre-commercial demonstration (PCD) operations.
Ascentage Pharma Group International : Nouveau potentiel au-dessus de la résistance | Zone bourse
08:13am, Monday, 22'nd Jun 2020Xconomy: Bio Roundup: A Royal IPO, Akili Arrives, Orca Bio Surfaces & More
03:33pm, Friday, 19'th Jun 2020
The biggest life sciences deal this week involves a company that doesn’t discover or develop drugs, or even sell them. Yet its mark is found on
3 Ultra-High-Growth Biopharma Stocks to Grab Now | The Motley Fool
10:25am, Friday, 19'th Jun 2020
Can the run for Sarepta Therapeutics, Viela Bio, and Aptose Biosciences continue?
Neurocrine Further Expands Its Pipeline With An Early-Stage Deal
12:31pm, Thursday, 18'th Jun 2020
Neurocrine and Takeda sign a partnership that brings potentially seven new drugs to Neurocrine for $120 million upfront. The lead drug, TAK-831, addresses the n
Xconomy: Engrail Therapeutics Launches With $32M to Develop New Neuro Drugs
12:00pm, Thursday, 18'th Jun 2020
Typically a new biotech assembles a group of investors that collectively puts in the money a fledgling company requires to develop or acquire potential
Neurocrine Biosciences和武田宣布合作开发和商业化精神疾病潜在治疗药物
12:00am, Thursday, 18'th Jun 2020
(美国商业资讯)--Neurocrine Biosciences, Inc. (Nasdaq:NBIX)和武田药品工业株式会社(Takeda Pharmaceutical Company Limited, TSE:4502/NYSE:TAK)(“武田”)今天宣布一项旨在开
Sign In
Buy NBIX